Prevalent tuberculosis and mortality among HAART initiators.
The effect of tuberculosis on mortality in people initiating highly-active antiretroviral therapy (HAART) remains unclear; here, we strengthened a previous cohort analysis. Multivariate Cox proportional hazards models were used to assess the association of baseline tuberculosis and time to all-cause mortality among HAART initiators. In reanalysis, treatment for tuberculosis at time of HAART initiation remained unassociated with increased risks of all-cause mortality, with adjusted hazard ratios ranging from 1.00 to 1.09.
Department of Obstetrics and Gynecology, Duke Global Health Institute, Duke University, Durham, North Carolina, USA. daniel.westreich@duke.edu
Daniel
D
Westreich
Matthew P
MP
Fox
Annelies
A
Van Rie
Mhairi
M
Maskew
D023241:Antiretroviral Therapy, Highly Active / Q000401:mortality; D015658:HIV Infections / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D015995:Prevalence; D012307:Risk Factors; D013019:South Africa / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000401:mortality*